medical research 14 ©Bicanski Eli Lilly and Company (NYSE:LLY) reported first-quarter results on Thursday that comfortably exceeded analyst expectations and lifted its full-year guidance, sending shares more than 5% higher in premarket trading. Adjusted earnings per share came in at $8.55, well above the $6.97 consensus estimate by $1.58. Revenue reached $19.8 billion, surpassing forecasts of $17.6 billion and marking a sharp 56% increase from $12.7 billion in the same quarter last year. The surge in ...